New research published in New England Journal of Medicine and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9–13 Sept) shows that a new class of insulin that is injected once a week is as effective as daily insulin injections for effective and safe blood sugar management in patients with type 2 diabetes. The study is by Dr. Carol Wysham, MultiCare Rockwood Center for Diabetes and Endocrinology, Spokane, WA, U.S., and colleagues.
This article was originally published on MedicalXpress.com
